Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1

Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1

US Patent 9850272 · Granted Dec 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Therapeutically active steroidal derivatives2022
Therapeutically active steroidal derivatives2022
Medicine for Covid-19 and treatment2021
Therapeutically active steroidal derivatives2020
Therapeutically active steroidal derivatives2020
Prodrugs of 17β-HSD1-inhibitors2020
Prodrugs of 17β-HSD1-inhibitors2020
Prodrugs of 17β-HSD1-inhibitors2020
Methods for the treatment of erectile dysfunction using fispemifene2019
Prodrugs of 17.BETA.-HSD1-inhibitors2019